首页> 外文期刊>Collection of Czechoslovak Chemical Communications >New effective synthesis of (N-acetyl- and N-stearoyl-2-amino-2-deoxy-beta-D-glucopyranosyl)-(1 -> 4)-muramoyl-L-2-aminobutanoyl-D-isoglutamine, analogs of GMDP with immunopotentiating activity
【24h】

New effective synthesis of (N-acetyl- and N-stearoyl-2-amino-2-deoxy-beta-D-glucopyranosyl)-(1 -> 4)-muramoyl-L-2-aminobutanoyl-D-isoglutamine, analogs of GMDP with immunopotentiating activity

机译:(N-乙酰基和N-硬脂酰基-2-氨基-2-脱氧-β-D-吡喃葡萄糖基)-(1-> 4)-村酰基-L-2-氨基丁酰基-D-异谷氨酰胺的新合成方法具有免疫增强活性的GMDP

获取原文
获取原文并翻译 | 示例
           

摘要

Ethyl 3,4,6-tri-O-benzyl-2-deoxy-2-phthalimido-1-thio-beta-D-glucopyranoside (5), prepared by benzylation of ethyl 2-deoxy-2-phthalimido-1-thio-beta-D-glucopyranoside (4), was transformed by reaction with bromine into 3,4,6-tri-O-benzyl-2-deoxy-2-phthalimido-beta-D-glucopyranosyl bromide (6). Thioglycoside 5 in the presence of methyl triflate and glycosylbromide 6 in the presence of silver triflate were used as glycosyl donors for condensation with benzyl 2-acetamido-3-O-allyl-6-O-benzyl-2-deoxy-alpha-D-glucopyranoside (7), to give benzyl 2-acetamido-3-O-allyl-6-O-benzyl-4-O-(3, 4,6-tri-O-benzyl-2-deoxy-2-phthalimido-beta-D-glucopyranosyl)-2-deoxy-alph a-D-glucopyranoside (8). Its reductive dephthaloylation with NaBH4/AcOH afforded benzyl 2-acetamido-3-O-allyl-4-O-(2-amino-3,4,6-tri-O-benzyl-2-deoxy-beta-D-gluco pyranosyl)-6-O-benzyl-2-deoxy-alpha-D-glucopyranoside (11). Compound 11 was N-acylated to give benzyl 2-acetamido-4-O-(2-acylamino-3,4,6-tri-O-benzyl-2-deoxy-beta-D-glucopyrano syl)-3-O-allyl-6-O-benzyl-2-deoxy-alpha-D-glucopyranosides (12a) or (12b). These compounds were converted into corresponding benzyl 2-acetamido-4-O-(2-acylamino-3,4,6-tri-O-benzyl-2-deoxy-beta-D-glucopyrano syl)-6-O-benzyl-3-O-carboxymethyl-2-deoxy-alpha-D-glucopyranosides which, by condensation with H-L-Abu-D-isoGln(OBzl) followed by hydrogenolysis of protective benzyl groups, furnished glycopeptides 16a and 16b. Intramolecular O-->N migration of the allyl protecting group followed by its reduction to the propyl residue by reaction of compound 8 with hydrazine or hydrazinium acetate, to give benzyl 2-acetamido-4-O-(3,4,6-tri-O-benzyl-2-deoxy-2-propylamino-beta-D-glucopyra nosyl)-6-O-benzyl-2-deoxy-alpha-D-glucopyranoside (9), is also described. [References: 18]
机译:通过对2-脱氧-2-邻苯二甲酰亚胺基-1-硫代乙基进行苄基化反应制得的乙基3,4,6-三-O-苄基-2-脱氧-2-邻苯二甲酰亚胺基-1-硫代-β-D-吡喃葡萄糖苷通过与溴反应将-β-D-吡喃葡萄糖苷(4)转化为3,4,6-三-O-苄基-2-脱氧-2-邻苯二甲酰亚胺基-β-D-吡喃葡萄糖基溴化物(6)。在三氟甲磺酸甲酯存在下的硫代糖苷5和在三氟甲磺酸银存在下的糖基溴化物6被用作与苄基2-乙酰氨基-3-O-烯丙基-6-O-苄基-2-脱氧-α-D-缩合的糖基供体。吡喃葡萄糖苷(7),得到苄基2-乙酰氨基-3-O-烯丙基-6-O-苄基-4-O-(3,4,6-三-O-苄基-2-脱氧-2-邻苯二甲酰亚胺-β -D-吡喃葡萄糖基)-2-脱氧-α-αD-吡喃葡萄糖苷(8)。用NaBH4 / AcOH进行还原性脱邻苯二甲酰化,得到苄基2-乙酰氨基-3-O-烯丙基-4-O-(2-氨基-3,4,6-三-O-苄基-2-脱氧-β-D-葡萄糖吡喃糖基)-6-O-苄基-2-脱氧-α-D-吡喃葡萄糖苷(11)。将化合物11 N-酰化,得到苄基2-乙酰氨基-4-O-(2-酰基氨基-3,4,6-三-O-苄基-2-脱氧-β-D-吡喃葡萄糖基)-3-O-烯丙基-6-O-苄基-2-脱氧-α-D-吡喃葡萄糖苷(12a)或(12b)。这些化合物被转化为相应的苄基2-乙酰氨基-4-O-(2-酰基氨基-3,4,6-三-O-苄基-2-脱氧-β-D-吡喃葡萄糖基)-6-O-苄基- 3-O-羧甲基-2-脱氧-α-D-吡喃葡萄糖苷,通过与HL-Abu-D-isoGln(OBzl)缩合,然后氢解保护性苄基,提供糖肽16a和16b。烯丙基保护基的分子内从O→N迁移,然后通过化合物8与肼或乙酸肼反应,还原成丙基残基,得到苄基2-乙酰氨基-4-O-(3,4,6-tri还描述了-O-苄基-2-脱氧-2-丙基氨基-β-D-吡喃葡糖基)-6-O-苄基-2-脱氧α-D-吡喃葡萄糖苷(9)。 [参考:18]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号